Factors Contributing to the Efficacy-Effectiveness Gap in the Case of Orphan Drugs for Metabolic Diseases
Crossref DOI link: https://doi.org/10.1007/s40265-017-0788-z
Published Online: 2017-07-27
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schuller, Y.
Hollak, C. E. M.
Gispen-de Wied, C. C.
Stoyanova-Beninska, V.
Biegstraaten, M.
Text and Data Mining valid from 2017-07-27